Revised: 7 November 2019

Information for Healthcare Professionals

This section provides information useful to healthcare professionals.

Healthcare Professional Information

Safety Communications

Unapproved Medicines

Adverse Reaction Reporting

Subscribe

Medsafe Advice

Date Type Title
21/04/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #3 – 20 March 2021
14/04/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #2 – 13 March 2021
13/04/2021CommitteesMedicines Adverse Reactions Committee - Minutes of 185th meeting - 11 March 2021
9/04/2021CommitteesAgenda for the 110th meeting of the Medicines Assessment Advisory Committee - 13 April 2021
7/04/2021Monitoring CommunicationUpdate - Possible risk of psoriasis exacerbation with bupropion
7/04/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #1 – 6 March 2021
29/03/2021ConsultationOutcome of the consultation on the proposed changes to paracetamol warning and advisory statements
23/03/2021Alert CommunicationUPDATE: Concern reported with the use of NovoRapid®Penfill® (insulin aspart; 3 mL cartridge) by type 1 diabetes patients
16/03/2021Alert CommunicationUPDATE - Rocuronium bromide solution for injection 10mg/mL, Hameln, and reports of lack of efficacy
4/03/2021PublicationsPrescriber Update - Vol. 42 No. 1 March 2021
4/03/2021CommitteesAgenda for the 66th meeting of the Medicines Classification Committee
3/03/2021Alert CommunicationYes! Cassette Pregnancy Test Kit (also known as Smith BioMed Rapid Pregnancy Test Kit) - Reports of false positives presenting as faint lines and inconclusive results
3/03/2021COVID-19ICMRA statement for healthcare professionals How COVID-19 vaccines will be regulated for safety and effectiveness

If you have an enquiry that is not answered by the information on the web site please contact us at askmedsafe@health.govt.nz.

Show menus
0 1 2 4 5 6 7 9 [ /